chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt reported to the vaccination area stating that she had a history of fainting after medical procedures, including vaccination.  Was with her mom, in case she had an issue. Vaccination without incident.  Kept pt at the vaccination area to observe.  About three minutes after receiving the vaccination, pt started to shake.  Was conversing.  Stated she was warm, so got her a cold bottle of water.  Stated she was dizzy so helped her to the floor to lay down.  She had contractions of her hands, which she stated that they were numb.  She recovered from the dizziness, but then had a panic attack.  Her BP was normal, but her heart rate became elevated.  Had her lay down until she felt better, helping to slow her breathing.  After about 40 minutes,p t felt good enough to sit in the recovery area.  Ensured she had water and some food to help prevent a blood sugar drop.
Difficulty Breathing and Walking 12/17/2009 Admitted to hospital for  Atrial fibrillation of 130
I am a physician. My so developed POTS syndrome after the second dose.  He was completely healthy before this., a competitive tennis player.
MUSCLE CRAMPS EVERY SINGLE DAY MOSTLY AT NIGHT SPECIALLY IN THE CALF AND THE THIGH AREA IN THE LEFT LEG; This spontaneous report received from a patient concerned a 39 year old male. The patient's height, and weight were not reported. The patient's past medical history included: gall bladder remover, and tonsil removed, and concurrent conditions included: alcohol user, non-smoker, hypertension, high cholesterol, gerd, back pain, depression, and anxiety. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAY-2021, the patient experienced muscle cramps every single day mostly at night specially in the calf and the thigh area in the left leg. Treatment medications (dates unspecified) included: morphine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from muscle cramps every single day mostly at night specially in the calf and the thigh area in the left leg. This report was non-serious.
No complaints, signs, symptoms, further AE/PQC.; a patient received expired VAQTA.; This spontaneous report was received from a consumer and refers to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history, drug reactions or allergies and concomitant medications was provided.  On 11-JAN-2021, the patient was vaccinated with expired dose of hepatitis a vaccine, inactivated (VAQTA) lot # T008149 (lot number T008149 has been verified to be a valid lot number for hepatitis a vaccine, inactivated (VAQTA) formulation vial), expiration date: 06-JAN-2021 (dose number, dose, route of administration and anatomical location were not reported) for prophylaxis.  No complains, signs, symptoms and adverse event was reported.
Within 15 seconds of receiving the vaccine patient started feeling hot and dizzy.  This progressed to include nausea, tachycardia, and shortness of breath without hypoxia.  Patient also stated it felt like she could not swallow and her throat felt tight.  She was given an Epi pen and symptoms started to improve but after about 20 minutes symptoms started worsening again.  At this time she was transported to the hospital ER for further evaluation and treatment.   Patient reports some continued episodes that resolve with Benadryl and time in the 1-2 days since getting the vaccine.
Body aches, Congestion, Shortness of Breath, Skin felt tight, Itching Eyes, Coughing, Upset Stomach, Tremors
Nurse provided Td to Left arm, then provided Hep B to R arm to the client at about 10:00 AM when client stood up, nurse noticed he was going to faint. She tried to assist the Client to the floor but he was to heavy and he fell and hit the floor.  After client fainted she placed ammonia under his nares in attempts to get client to respond.  911 was activated and code blue was called.  He was breathing the whole time but did lost his color for a few minutes. Vital signs were obtain B/P 118/80 Pulse 68 Resp 18 and regular.   City Ambulance - Paramedics arrived and checked client for any injuries.  After about 30 minutes client was released to his wife. Client was instructed by LVN on side effects and provided with V.I.S form for the vaccines he received.
Bad rash all over the body; Fever; Chills; Muscle pain; Feeling tired; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), RASH (Bad rash all over the body), FATIGUE (Feeling tired), PYREXIA (Fever) and CHILLS (Chills) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and FATIGUE (Feeling tired). On 22-Feb-2021, the patient experienced RASH (Bad rash all over the body), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Muscle pain). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PREDNISONE for Rash, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm), RASH (Bad rash all over the body), FATIGUE (Feeling tired), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Pt has seen family MD. Elidel cream, not working. A few red bumps around injection site still apparent after 1 month. Area is still red. It began as solid red circle and now is only a few red bumps. No other symptoms.
Reported mild muscle and body aches on 1/21 but resolved by 1/26
The pt developed a fluffed blotches of red areas at injection site post receiving vaccines. Resolved spontaneously within 1 hour.
Intense congestion, frequent sneezing and coughing,  with gradual reduction, until midnight. Slept then continued somewhat throughout  next day.  Red rash over torso - front and back - and inner arms. Slight nausea, no desire to eat. Extreme fatigue, off-balance Continuance of reduced symptoms, today the fourth day.
Military mobilization received small pox vaccine for overseas deployment.  Pustules below the belt line and just above genitals and on buttocks with itching and sensitivity appeared a few weeks later.  Went on sick call a few weeks after symptoms and diagnosis was unknown but given Ketoconazole topical solution to relieve symptoms.  Reappears every 2-3 months, saw my healthcare provider at home around July 2013 and he diagnosed as herpes and prescribed Valacyclovir HCL1.
Monday I felt like I had sinus issues.; I have now tested positive; I have now tested positive; on Sunday I started having some chills and sniffles; on Sunday I started having some chills and sniffles; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date unspecified), via an unspecified route of administration on 29Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that on Sunday, 31Jan2021, the patient started having some chills and sniffles. On Monday, 01Feb2021, the patient felt like she had sinus issues. On Tuesday, 02Feb2021, a friend said they were tested positive and recommended she get tested. The patient reported that she now tested positive in Feb2021. Patient was asking what to do about her second dose. Outcome of events was unknown.   Information on Lot/Batch number has been requested.
Information has been received from a health department coordinator concerning a 49-year-old male patient with a history of a tick bite in September 1990 who on 25AUG9? was vaccinated with RECOMBIVAX HB vaccine. On 01FEB93 the patient developed swelling in the joints of his fingers, arthralgia, itching in his legs, fatigue, loss of memory, lack of ability to concentrate, a rash with spots on his hands, one pupil was not able to fully dilate and he had loss of vision. Also, the patient experienced dizziness and -his balance was off". He was vaccinated with another dose of RECOMBIVAX HB vaccine on 24FEB93. Follow-up information received in June, 1997 revealed that the above experience "were seen soon after the completion of the RECOMBIVAX HB series". On 12MAY97 the patient was seen by a physician who "ruled out Lyme disease and diagnosed him with erythema multiforme". At the time of the report, the patient was "still being treated with prednisone for the swelling with some success". No further details were provided.
Seven days post injection, itchy, red, throbbing, tingling, swollen area near injection site.
Flu like symptoms, soreness, inflammation spreading around site area approximately 6 inches in area. I have been applying ice to the area. Taking Ibuprofen and started BENADRYL after redness was still spreading on the 5th day.
THE INDIVIDUAL RECEIVED LESS THAN 0.5ML OF THE JANSSEN COVID-19 VACCINE AS THE INITIAL DOSE (APPROXIMATELY AROUND 0.3ML); OFF LABEL USE; This spontaneous report received from a health care professional concerned a 33 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 213D21A, and expiry: 11-APR-2022) dose was not reported, administered on 01-DEC-2021 for prophylactic vaccination. No concomitant medications were reported.  On 01-DEC-2021, the patient experienced the individual received less than 0.5ml of the janssen covid-19 vaccine as the initial dose (approximately around 0.3ml). On 01-DEC-2021, the patient experienced off label use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the the individual received less than 0.5ml of the janssen covid-19 vaccine as the initial dose (approximately around 0.3ml) and off label use was not reported. This report was non-serious. This case, from the same reporter is linked to 20211210684, 20211210160, 20211210058, 20211209551 and 20211209843.
Fever, serious headache, diarrhea, sore throat for 3 full days.  Treating with Tylenol and Aleve and cold compresses to keep fever down.
had blisters in his throat; and on the left lower portion of his gums.; pain on his left face/minimal pain remaining on his face; gum; pain in ear; eye; throat; scalp; This case was reported by a other health professional via call center representative and described the occurrence of throat blister in a 54-year-old male patient who received Herpes zoster (Shingrix) (batch number GB429, expiry date 5th December 2021) for prophylaxis.   On 24th July 2020, the patient received Shingrix. On 12th August 2020, 19 days after receiving Shingrix, the patient experienced throat blister (serious criteria GSK medically significant), gingival blister, facial pain, gum pain, ear pain, eye pain, throat pain and scalp pain. On an unknown date, the outcome of the throat blister, gingival blister and facial pain were recovering/resolving and the outcome of the gum pain, ear pain, eye pain, throat pain and scalp pain were not recovered/not resolved.   It was unknown if the reporter considered the throat blister, gingival blister, facial pain, gum pain, ear pain, eye pain, throat pain and scalp pain to be related to Shingrix.  Additional details were provided as follows: The patient received the dose of shingrix and developed pain on his left face, gums, ears, eye, throat, scalp and ear. In addition to the left sided pain, he had blisters in his throat and on the left lower portion of his gums.  The blisters had resolved, all except 1, per the reporter. The patient reported minimal pain remained on his face.  The reporter did not diagnose the incident as shingles, nor prescribed any medication. The reported batch number was updated from  BG429 to GB429, as per sales data sheet. The follow up consent was granted
generalized flushing of both arms and neck 30 mins post vaccine (similar to past reaction to PCN)
Within 24 hours felt nauseous, tinnitus in both ears, metal taste in my mouth
Having body aches; Chills; Slight headache; This case was reported by a consumer via interactive digital media and described the occurrence of general body pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of no adverse event (1st dose received on an unknown date).   On 13th January 2021, the patient received the 2nd dose of Shingrix. On 14th January 2021, 1 days after receiving Shingrix, the patient experienced general body pain, chills and headache. On an unknown date, the outcome of the general body pain, chills and headache were unknown.   It was unknown if the reporter considered the general body pain, chills and headache to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The patient received the 2nd dose of Shingrix a day before reporting. The patient experienced general body pain, chills and headache on the day of reporting. The reporter wanted to know were the two shots the same.
Pt recvd vax 2nd dose of vax on 16APR92 & inject site became sore, tender, & red w/urticaria & itching; pt went to MD office & was treated w/DPH; pt recovered; No further detail was provided;
a patient received an extra dose of GARDASIL 9; no adverse event; This spontaneous report was received from a physician via company Representative and refers to a patient of unknown age and gender.  The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On an unknown date, the patient started vaccination with 9-valent Human Papillomavirus (types 16, 18, 31, 33, 45, 52, 58, 6 and 11) recombinant vaccine (GARDASIL 9) (dosage regimen, route of administration, lot #, and expiry date were not reported) as prophylaxis.  On an unknown date, the patient received an extra dose of 9-valent Human Papillomavirus (types 16, 18, 31, 33, 45, 52, 58, 6 and 11) recombinant vaccine (GARDASIL 9) (dosage regimen, route of administration, lot #, and expiry date were not reported) as prophylaxis.(Extra dose administered). No adverse event was reported.  This is a non-valid case due to lack of patient's identifiers.  Follow-up information has been received from a vaccine provider, on 19-AUG-2022.  The patient's demographics were updated. On 28-JUL-2022 the patient was shown to need a pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) vaccine but was in adversely given a fourth dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (conflicting information, also reported as hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) [GARDASIL 9]) vaccine inactivated, intramuscular, right deltoid (not valid lot number 4019412 [expiration date 30-OCT-2023]) as soon as the incident was noticed the vaccine manufacturer was notified.
woke up from sleeping feeling sick sweating and started vomiting tightness in my chest and  dizzy with a headache
Pt states - temp 104 degrees at 10 pm 11/03/05 chills, headache, sob - did not go to ER or see MD. States she had fever and felt bad until 11/08/2005
"pt recv vax 22JUL96 & 27JUL96 pt dx w/lt OM & tx w/amoxil;31JUL96 pt devel a throat infect 104, fever & cont LOM;tx w/Suprax;devel splotchy maculopapular rash, diff rubella versus rubeola;MD visit required;"
This spontaneous report was received from a Registered nurse regarding a 16 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 28-JUL-2017, the patient was vaccinated with improperly stored dose of GARDASIL 9 lot# N004798 with expiration date: 31-OCT-2019 (dosing details and route of administration was not reported) for prophylaxis (product storage error). No adverse effects were reported. The storage temperature was 47 degrees Fahrenheit to 77 degrees Fahrenheit (49F) and time frame was 14 hours. There was no previous temperature excursion. Digital data logger was involved. No product quality complaint was involved. This is one of the several reports from the same reporter.; Sender's Comments: US-009507513-1804USA005153:
Patient reported symptoms of chills brain fog and armpit swelling for full 24 hours started about 4 hours after vaccine administration.
arm soreness at vaccination site,  flu like symptom-fever, body aches, chills, warm sensation
Red rash 3 inches below injection, hot to touch, 5 inches across, started Tuesday after Monday injection,  still there Wednesday after Monday injection   Red circle, itchy, hot to touch, very sore at injection ,  started Tuesday after Monday injection, still there Wednesday after Monday injection   Fever 100.3,, started Tuesday after Monday injection, now gone Wednesday after Monday injection    Flu like symptoms started Tuesday after Monday injection, still there Wednesday after Monday injection
Pt admitted to inpatient rehab hospital following a stroke with PMH significant for hypertension and hyperlipidemia.  She had  multiple cardiac arrests secondary to massive pulmonary embolism and right ventricular failure.    Patient expired on 5/20/2021 upon chart review it was identified patient had received J&J vaccine on 4/7/2021.
Loss of range of motion in her left arm; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Loss of range of motion in her left arm) and VACCINATION SITE PAIN (Arm pain) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Loss of range of motion in her left arm) and VACCINATION SITE PAIN (Arm pain). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Loss of range of motion in her left arm) and VACCINATION SITE PAIN (Arm pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No conmeds reported.    Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
pt brought into clinic @ 2PM had solid red swollen area on lt lateral thigh approx 1" above knee to top of leg; warm & tender to touch;
Patient developed rash/ bumps along her back. She went to an urgent care facility on  8/1 and was diagnosed with shingles. She was given treatment.
Two days post vax, pt's signs and symptoms included near circumferential swelling and erythema of entire upper arm and half of forearm Some local myalgias and arthralgias. Pt did not report any systemic symptoms. Pt placed on oral prednisone, histamine blocking agents and had resolution within 24 hours.
G40.909 EPILEPSY, UNSPECIFIED 5/6/2021 BPH W LOWER URINARY TRACT SYMPTOMS G40.A09 CHILDHOOD ABSENCE EPILEPSY 5/9/2021 BPH W LOWER URINARY TRACT SYMPTOMS
Night of the shot - strong/high fever for 12 hours with chest tightness.  Since, to present day - persistent chest tightness.
Dysdiadochokinesia. C/O headache and pain in idiopathic autoimmune cerebellitis; symptoms of ataxia began on 11/27 getting progressively worse until admitted to facility on 11/30.  Inpatient care including high dose steroids 12/4-12/7 with discharge 12/7 - baseline balance obtained.  Follow up care includes pediatrician, blood work, and PT. 3/3/08-records received-for DOS 11/31-12/7/07-DC DX: likely idiopathic autoimmune cerebritis. Presented with 3 days of clumsiness and stumbling, wobbly gait and intermittent fevers to a max of 101, 3 episodes of emesis after car rides. Decreased p.o. intact. In ED had bilateral dysmetria, positive Romberg sign broad based ataxia. Dysdiadochokinesia. C/O headache and pain in legs.
Headache, Myalgia, Arthralgia, Tachycardia, CHILLS, FATIGUE, SORE ARM Narrative:
Caller stated after her second dose, her arm hurt.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Tylenol, notes: Caller takes a Tylenol every day. She got her second dose of the Pfizer COVID vaccine and wants to know if she can still take Tylenol after the dose. Vaccination history included: Bnt162b2 (Suspect Product(s): Covid-19 Vaccine, Verbatim and Event Description: Caller stated she takes a Tylenol every day. Today she got her first dose of the Covid vaccine), for Covid-19 Immunisation. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Caller stated after her second dose, her arm hurt.".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Huge bump and redness at vaccine site. Bones hurt all throughout the body. It hurts even to lay down. My skull even hurts. Fever and dizziness.
VACCINE WAS GIVEN AFTER THE 6 HOURS LIMIT; POOR QUALITY PRODUCT ADMINISTERED; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 11-JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 11-JUN-2021, the subject experienced vaccine was given after the 6 hours limit. On 11-JUN-2021, the subject experienced poor quality product administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vaccine was given after the 6 hours limit and poor quality product administered was not reported. This report was non-serious.
Within 10 minutes after vaccine, patient complained of difficulty swallowing, some neck muscle stiffness, and mild headache. Treated with Benadryl 25 mg PO given and Gatorade. Patient observed in urgent care for 1 hour.
my bowel movement has almost no smell; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (my bowel movement has almost no smell) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ANOSMIA (my bowel movement has almost no smell). At the time of the report, ANOSMIA (my bowel movement has almost no smell) outcome was unknown.            No concomitant medications were provided.  No treatment medications were provided.